181 related articles for article (PubMed ID: 37684436)
1. Exploration of Key Immune-Related Transcriptomes Associated with Doxorubicin-Induced Cardiotoxicity in Patients with Breast Cancer.
Xiong D; Yang J; Li D; Wang J
Cardiovasc Toxicol; 2023 Oct; 23(9-10):329-348. PubMed ID: 37684436
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel biomarkers involved in doxorubicin-induced acute and chronic cardiotoxicity, respectively, by integrated bioinformatics.
Qian H; Qian Y; Liu Y; Cao J; Wang Y; Yang A; Zhao W; Lu Y; Liu H; Zhu W
Front Cardiovasc Med; 2022; 9():996809. PubMed ID: 36712272
[TBL] [Abstract][Full Text] [Related]
3. Transcriptome profiling revealed multiple genes and ECM-receptor interaction pathways that may be associated with breast cancer.
Bao Y; Wang L; Shi L; Yun F; Liu X; Chen Y; Chen C; Ren Y; Jia Y
Cell Mol Biol Lett; 2019; 24():38. PubMed ID: 31182966
[TBL] [Abstract][Full Text] [Related]
4. Genomic profiling reveals the potential role of TCL1A and MDR1 deficiency in chemotherapy-induced cardiotoxicity.
McCaffrey TA; Tziros C; Lewis J; Katz R; Siegel R; Weglicki W; Kramer J; Mak IT; Toma I; Chen L; Benas E; Lowitt A; Rao S; Witkin L; Lian Y; Lai Y; Yang Z; Fu SW
Int J Biol Sci; 2013; 9(4):350-60. PubMed ID: 23630447
[TBL] [Abstract][Full Text] [Related]
5. Bioinformatic analysis of peripheral blood miRNA of breast cancer patients in relation with anthracycline cardiotoxicity.
Yadi W; Shurui C; Tong Z; Suxian C; Qing T; Dongning H
BMC Cardiovasc Disord; 2020 Feb; 20(1):43. PubMed ID: 32013934
[TBL] [Abstract][Full Text] [Related]
6. microRNA miR-133a as a Biomarker for Doxorubicin-Induced Cardiotoxicity in Women with Breast Cancer: A Signaling Pathway Investigation.
Alves MT; da Conceição IMCA; de Oliveira AN; Oliveira HHM; Soares CE; de Paula Sabino A; Silva LM; Simões R; Luizon MR; Gomes KB
Cardiovasc Toxicol; 2022 Jul; 22(7):655-662. PubMed ID: 35524907
[TBL] [Abstract][Full Text] [Related]
7. Phloretin alleviates doxorubicin-induced cardiotoxicity through regulating Hif3a transcription via targeting transcription factor Fos.
Li X; Sun T; Liu J; Wei S; Yang Y; Liu J; Zhang B; Li W
Phytomedicine; 2023 Nov; 120():155046. PubMed ID: 37659297
[TBL] [Abstract][Full Text] [Related]
8. GPR91 Receptor Mediates Protection against Doxorubicin-Induced Cardiotoxicity without Altering Its Anticancer Efficacy. An In Vitro Study on H9C2 Cardiomyoblasts and Breast Cancer-Derived MCF-7 Cells.
Dallons M; Alpan E; Schepkens C; Tagliatti V; Colet JM
Cells; 2020 Sep; 9(10):. PubMed ID: 32992522
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers for Presymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients.
Todorova VK; Makhoul I; Siegel ER; Wei J; Stone A; Carter W; Beggs ML; Owen A; Klimberg VS
PLoS One; 2016; 11(8):e0160224. PubMed ID: 27490685
[TBL] [Abstract][Full Text] [Related]
10. Human induced pluripotent stem cell-derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity.
Burridge PW; Li YF; Matsa E; Wu H; Ong SG; Sharma A; Holmström A; Chang AC; Coronado MJ; Ebert AD; Knowles JW; Telli ML; Witteles RM; Blau HM; Bernstein D; Altman RB; Wu JC
Nat Med; 2016 May; 22(5):547-56. PubMed ID: 27089514
[TBL] [Abstract][Full Text] [Related]
11. Weighted gene co-expression network-based approach to identify key genes associated with anthracycline-induced cardiotoxicity and construction of miRNA-transcription factor-gene regulatory network.
Wan G; Chen P; Sun X; Cai X; Yu X; Wang X; Cao F
Mol Med; 2021 Nov; 27(1):142. PubMed ID: 34732131
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatics identification of potential candidate blood indicators for doxorubicin-induced heart failure.
Wan GX; Ji LH; Xia WB; Cheng L; Zhang YG
Exp Ther Med; 2018 Sep; 16(3):2534-2544. PubMed ID: 30186487
[TBL] [Abstract][Full Text] [Related]
13. Circulating miRNA Profiles of Doxorubicin-induced Cardiotoxicity in Breast Cancer Patients.
Todorova VK; Makhoul I; Wei J; Klimberg VS
Ann Clin Lab Sci; 2017 Mar; 47(2):115-119. PubMed ID: 28442511
[TBL] [Abstract][Full Text] [Related]
14. Circulating miR-1 as a potential biomarker of doxorubicin-induced cardiotoxicity in breast cancer patients.
Rigaud VO; Ferreira LR; Ayub-Ferreira SM; Ávila MS; Brandão SM; Cruz FD; Santos MH; Cruz CB; Alves MS; Issa VS; Guimarães GV; Cunha-Neto E; Bocchi EA
Oncotarget; 2017 Jan; 8(4):6994-7002. PubMed ID: 28052002
[TBL] [Abstract][Full Text] [Related]
15. MiR-15b-5p is Involved in Doxorubicin-Induced Cardiotoxicity via Inhibiting Bmpr1a Signal in H9c2 Cardiomyocyte.
Wan GX; Cheng L; Qin HL; Zhang YZ; Wang LY; Zhang YG
Cardiovasc Toxicol; 2019 Jun; 19(3):264-275. PubMed ID: 30535663
[TBL] [Abstract][Full Text] [Related]
16. miRNA expression patterns in chemoresistant breast cancer tissues.
Lv J; Xia K; Xu P; Sun E; Ma J; Gao S; Zhou Q; Zhang M; Wang F; Chen F; Zhou P; Fu Z; Xie H
Biomed Pharmacother; 2014 Oct; 68(8):935-42. PubMed ID: 25451164
[TBL] [Abstract][Full Text] [Related]
17. Immune response proteins as predictive biomarkers of doxorubicin-induced cardiotoxicity in breast cancer patients.
Yu LR; Cao Z; Makhoul I; Daniels JR; Klimberg S; Wei JY; Bai JP; Li J; Lathrop JT; Beger RD; Todorova VK
Exp Biol Med (Maywood); 2018 Feb; 243(3):248-255. PubMed ID: 29224368
[TBL] [Abstract][Full Text] [Related]
18. Dapagliflozin suppresses ER stress and protects doxorubicin-induced cardiotoxicity in breast cancer patients.
Chang WT; Lin YW; Ho CH; Chen ZC; Liu PY; Shih JY
Arch Toxicol; 2021 Feb; 95(2):659-671. PubMed ID: 33211168
[TBL] [Abstract][Full Text] [Related]
19. Identification of key tumor stroma-associated transcriptional signatures correlated with survival prognosis and tumor progression in breast cancer.
Uddin MN; Wang X
Breast Cancer; 2022 May; 29(3):541-561. PubMed ID: 35020130
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional co-activators YAP1-TAZ of Hippo signalling in doxorubicin-induced cardiomyopathy.
Berecz T; Yiu A; Vittay O; Orsolits B; Mioulane M; Dos Remedios CG; Ketteler R; Merkely B; Apáti Á; Harding SE; Hellen N; Foldes G
ESC Heart Fail; 2022 Feb; 9(1):224-235. PubMed ID: 34931757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
